These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Treatment of multiple sclerosis with various interferons: the cons. Johnson KP Neurology; 1988 Jul; 38(7 Suppl 2):62-5. PubMed ID: 3133576 [TBL] [Abstract][Full Text] [Related]
11. [Interferon-producing and cytotoxic activity of natural killer cells in multiple sclerosis patients]. Sorokin AM; Koval'chuk LV; Tunkel' OI; Cheknev SB Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(2):211-5. PubMed ID: 2437743 [TBL] [Abstract][Full Text] [Related]
12. Intrathecally administered natural human fibroblast interferon reduces exacerbations of multiple sclerosis. Results of a multicenter, double-blind study. Jacobs L; Salazar AM; Herndon R; Reese PA; Freeman A; Jozefowicz R; Cuetter A; Husain F; Smith WA; Ekes R Arch Neurol; 1987 Jun; 44(6):589-95. PubMed ID: 3579676 [TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha and transfer factor in the treatment of multiple sclerosis: a double-blind, placebo-controlled trial. AUSTIMS Research Group. J Neurol Neurosurg Psychiatry; 1989 May; 52(5):566-74. PubMed ID: 2659737 [TBL] [Abstract][Full Text] [Related]